Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) EBIT Margin (2016 - 2025)

Historic EBIT Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 0.15%.

  • AtriCure's EBIT Margin rose 65400.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.11%, marking a year-over-year increase of 25300.0%. This contributed to the annual value of 8.6% for FY2024, which is 19200.0% down from last year.
  • As of Q3 2025, AtriCure's EBIT Margin stood at 0.15%, which was up 65400.0% from 4.55% recorded in Q2 2025.
  • In the past 5 years, AtriCure's EBIT Margin registered a high of 140.04% during Q3 2021, and its lowest value of 26.8% during Q1 2021.
  • In the last 5 years, AtriCure's EBIT Margin had a median value of 8.14% in 2023 and averaged 2.52%.
  • In the last 5 years, AtriCure's EBIT Margin skyrocketed by 1473200bps in 2021 and then plummeted by -1529200bps in 2022.
  • Over the past 5 years, AtriCure's EBIT Margin (Quarter) stood at 17.08% in 2021, then surged by 72bps to 4.7% in 2022, then tumbled by -73bps to 8.14% in 2023, then tumbled by -44bps to 11.69% in 2024, then soared by 101bps to 0.15% in 2025.
  • Its EBIT Margin was 0.15% in Q3 2025, compared to 4.55% in Q2 2025 and 4.82% in Q1 2025.